Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain

NAActive, not recruitingINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

May 1, 2025

Study Completion Date

November 30, 2025

Conditions
Opioid UsePainMarijuana Use
Interventions
DRUG

Medical Marijuana

Patients in this group can choose what type, how much, and when to use medical marijuana to use.

BEHAVIORAL

Prescription Opioid Taper Support (POTS)

Prescription Opioid Taper Support (POTS), a manualized behavioral prescription opioid taper support intervention developed by consultant, will be offered weekly to all participants to support behavioral self-management of pain and structured, voluntary taper of COT dose.

Trial Locations (3)

04102

Maine Medical Center, Portland

02114-2523

Massachusetts General Hospital, Boston

02139

Cambridge Health Alliance, Cambridge

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cambridge Health Alliance

OTHER

collaborator

MaineHealth

OTHER

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Massachusetts General Hospital

OTHER

NCT04827992 - Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain | Biotech Hunter | Biotech Hunter